These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1726274)

  • 1. [Levels of tumor necrosis factor and interleukin 1 in uremia and in hemodialysis].
    Peona C; Fortina A; Colombo P; Filiberti O; Cagna G; Costantini L; Porcu M
    Minerva Urol Nefrol; 1991; 43(3):175-9. PubMed ID: 1726274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha.
    Herbelin A; Nguyen AT; Zingraff J; Ureña P; Descamps-Latscha B
    Kidney Int; 1990 Jan; 37(1):116-25. PubMed ID: 2299797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of cytokines in hemodialysis.
    Tetta C; Camussi G; Turello E; Salomone M; Aimo G; Priolo G; Segoloni G; Vercellone A
    Blood Purif; 1990; 8(6):337-46. PubMed ID: 2093331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of interleukin-1 and tumor necrosis factor during in vitro hemodialysis with different membranes.
    Schindler R; Lonnemann G; Shaldon S; Koch KM; Dinarello CA
    Contrib Nephrol; 1989; 74():58-65. PubMed ID: 2702147
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of neutrophil apoptosis by uremic plasma during hemodialysis.
    Jaber BL; Balakrishnan VS; Cendoroglo MN; Perianayagam MC; King AJ; Pereira BJ
    Blood Purif; 1998; 16(6):325-35. PubMed ID: 10343079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine release and serum lipoprotein (a) alterations during hemodialysis.
    Tzanatos HA; Agroyannis B; Chondros C; Kapetanaki A; Fourtounas C; Soubassi L; Kopelias I
    Artif Organs; 2000 May; 24(5):329-33. PubMed ID: 10848673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of biofiltration in uremic children.
    De Palo T; Sorino P; Bellantuono R; Colella V; Caringella DA
    Int J Artif Organs; 1986 Dec; 9 Suppl 3():89-91. PubMed ID: 3557683
    [No Abstract]   [Full Text] [Related]  

  • 8. Polyacrilonytrile versus cuprophan membranes for hemodialysis: evaluation of efficacy and biocompatibility by platelet aggregation studies.
    Berrettini M; Buoncristiani U; Parise P; Ballatori E; Nenci GG
    Int J Artif Organs; 1981 Sep; 4(5):218-22. PubMed ID: 7319659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced release of TNF-alpha, but not IL-1 beta, from uremic blood after endotoxin stimulation.
    Powell AC; Bland LA; Oettinger CW; McAllister SK; Oliver JC; Arduino MJ; Favero MS
    Lymphokine Cytokine Res; 1991 Oct; 10(5):343-6. PubMed ID: 1768736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of serum levels of macrophage colony-stimulating factor (M-CSF) in patients with uremia.
    Kawano Y; Takaue Y; Motoyoshi K; Minakuchi J; Kawashima S; Saito S; Hirao A; Sato J; Shimizu T; Kuroda Y
    Exp Hematol; 1993 Feb; 21(2):220-3. PubMed ID: 8425560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imbalance of Th22/Treg cells causes microinflammation in uremic patients undergoing hemodialysis.
    Ren T; Xiong J; Liu G; Wang S; Tan Z; Fu B; Zhang R; Liao X; Wang Q; Guo Z
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31427482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro studies of endotoxin transfer across cellulosic and noncellulosic dialysis membranes. II. Interleukin-1 production.
    Herbelin A; Ureña P; Man NK; Drüeke T; Descamps-Latscha B
    Contrib Nephrol; 1989; 74():79-85. PubMed ID: 2702150
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytokine production during hemodialysis: effects of dialytic membrane and complement activation.
    Lin YF; Chang DM; Shaio MF; Lu KC; Chyr SH; Li BL; Sheih SD
    Am J Nephrol; 1996; 16(4):293-9. PubMed ID: 8739281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma interleukin-18 levels in hemodialysis patients: increased by dialysis process and association with interleukin-6 and tumor necrotic factor-alpha.
    Chiang CK; Huang JW; Hsu SP; Ho TI; Pai MF; Peng YS; Liu SH; Hung KY; Tsai TJ
    Blood Purif; 2006; 24(2):174-9. PubMed ID: 16357479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation in dialysis: effects on cytokines, lymphocyte activation and beta 2 microglobulin.
    Gardinali M; Calcagno A; Conciato L; Agostoni A; Rosti A; Cori P; Vozzo N; Moroni A; Anelli A; Zoni U
    Int J Artif Organs; 1994 Jun; 17(6):337-44. PubMed ID: 7806419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodialysis-associated platelet loss: study of the relative contribution of dialyzer membrane composition and geometry.
    Docci D; Turci F; Del Vecchio C; Bilancioni R; Cenciotti L; Pretolani E
    Int J Artif Organs; 1984 Nov; 7(6):337-40. PubMed ID: 6526528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of different dialyzer membranes on serum angiotensin-converting enzyme during hemodialysis.
    Docci D; Delvecchio C; Turci F; Baldrati L; Gollini C
    Int J Artif Organs; 1988 Jan; 11(1):28-32. PubMed ID: 2834297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRP, IL‑2 and TNF‑α level in patients with uremia receiving hemodialysis.
    Li G; Ma H; Yin Y; Wang J
    Mol Med Rep; 2018 Feb; 17(2):3350-3355. PubMed ID: 29257244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of tumor necrosis factor alpha in postdialysis fatigue.
    Dreisbach AW; Hendrickson T; Beezhold D; Riesenberg LA; Sklar AH
    Int J Artif Organs; 1998 Feb; 21(2):83-6. PubMed ID: 9569129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient survival on PAN/AN 69 membrane hemodialysis.
    Chanard J
    J Am Soc Nephrol; 1994 Jun; 4(12):2050-1. PubMed ID: 7919158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.